ARGX Q2 2021 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena

ARGXargenx SE

$46B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$420M+1277.4% YoY

Gross Profit

$189M45.1% margin

Operating Income

$80M19.1% margin

Net Income

$53M12.7% margin

EPS (Diluted)

$0.99

Cash Flow

Operating Cash Flow

-$190M

Free Cash Flow

-$192M

Stock-Based Comp.

$92M

Balance Sheet

Total Assets

$3.2B

Total Liabilities

$261M

Stockholders' Equity

$3.0B

Cash & Equivalents

$1.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$420M	$31M	+1277.4%
Gross Profit	$189M	-$138M	+237.4%
Operating Income	$80M	-$198M	+140.6%
Net Income	$53M	-$202M	+126.4%

Geographic Segments

U

$317M67%

C

$152M32%

Countries Other Than United States And China

$1M0%